Professor Qingqing Cai has been engaged in clinical oncology work for more than 20 years, specializing in the area of clinical, translational, and basic research on lymphoma, nasopharyngeal carcinoma, head and neck squamous cell carcinoma. She served as the leader of the lymphoma Group of Guangdong Medical Association, and has won the "2020 People's Good Doctor" (Lymphoma) Outstanding Contribution Award”, the first batch of “Outstanding Young Medical Talents in Guangdong Province”, and other titles. In the past 5 years, she has published 17 articles as the corresponding author (or co-corresponding author) in prestigious journals including Blood, Leukemia, Clin Cancer Res, Signal Transduct Target Ther, etc., and presided over several national natural science foundations and provincial foundations. 

Specializes in clinical, transformation and basic research of lymphoma; and in clinical research on nasopharyngeal carcinoma, head and neck squamous cell carcinoma.

Bachelor’s degree, former Sun Yat-sen University of Medical Sciences, China, 1993-1998.

Master’s degree in Oncology, Sun Yat-Sen University, China, 2001-2004

Ph.D in Oncology, Sun Yat-Sen University, China, 2006-2009

Visiting scholar, MD Anderson Cancer Center, US, 2013-2014.

1. A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma patients undergoing non-anthracyline-based treatment: a retrospective, international, cohort study.Xiao-Peng Tian# ; Shu-Yun Ma# ; Ken H. Young# ; Choon Kiat Ong# ; Yan-Hui Liu# ; Zhi-Hua Li; Qiong-Li Zhai; Hui-Qiang Huang; Tong-Yu Lin; Zhi-Ming Li; Zhong-Jun Xia; Li-Ye Zhong; Hui-Lan Rao; Mei Li; Jun Cai; Yu-Chen Zhang; Fen Zhang; Ning Su; Peng-Fei Li; Feng Zhu; Zijun Y Xu-Monette; Esther Kam Yin Wong; Jeslin Chian Hung Ha; Lay Poh Khoo; Le Ai; Run-Fen Cheng; Jing Quan Lim; Sanjay de Mel; Siok-Bian Ng; Soon Thye Lim; Cai QQ*.Blood  2021.

2. Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.Yuchen Zhang#; Shuyun Ma#;  Jun Cai#;Yu Yang#; Hongmei Jing#;Yuerong Shuang; Zhigang Peng; Bingzong Li; Panpan Liu1;  Zhongjun Xia; Yi Xia1; Yan Gao; Daoguang Chen; Jianyang Lin; Qihui Li; Shenghua Xu; Qingyuan Xu; Han; Zhang; Huiqiang Huang *;  Qingqing Cai*.Am J Hematol 2021.

3. Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.Jun Cai# ; Panpan Liu# ; Huiqiang Huang# ; Yajun Li; Shuyun Ma; Hui Zhou; Xiaopeng Tian; Yuchen Zhang; Yan Gao; Yi Xia; Xuanye Zhang; Hang Yang; Lirong Li; Cai QQ*.Signal Transduction and Targeted Therapy 2020.

4. A CpG methylation classifier to predict relapse in adults with T-cell lymphoblastic lymphoma.Tian XP# ; Su N# ; Wang L# ; Huang WJ# ; Liu YH; Zhang X; Huang HQ; Lin TY; Ma SY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sun C; Sang W; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Pan XY; Hai L; Li GW; Song LY; Kang TB; Xie D* ; Cai QQ*.CLINICAL CANCER RESEARCH 2020.

5. A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: A multicenter study  Running Title: A Gene Classifier to Predict Adult T-LBL Prognosis.Tian XP# ; Xie D# ; Huang WJ# ; Ma SY# ; Wang L; Liu YH; Zhang X; Huang HQ; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Pan XY; Lan H; Li GW; Liu L; Bao HZ; Song LY; Kang TB; Cai QQ*.Leukemia 2020.

6. BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.Xiao-Peng Tian* Jun Cai* Shu-Yun Ma* Yu Fang* Hui-Qiang Huang  Tong-Yu Lin  Hui-Lan Rao Mei Li  Zhong-Jun Xia Tie-Bang Kang Dan Xie Qing-Qing Cai# .Cancer Communications 2020.

7. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.Tian XP# ; Huang WJ# ; Huang HQ# ; Liu YH; Wang L; Zhang X; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Wu CL; Zhang MY; Wang HY; Xie D* ; Cai QQ* .Leukemia 2019.

8. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.Peng RJ# ; Han BW# ; Cai QQ# ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK* ; Zeng YX* ; Bei JX* ;.Leukemia 2019.

9. IL-2R alpha up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma. Wang L#* ; Bi XW# ; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ*. Cancer Communications 2018.

10. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study. Hu, Li-Yang; Xu, Xiao-Lu; Rao, Hui-Lan; Chen, Jie; Lai, Ren-Chun; Huang, Hui-Qiang; Jiang, Wen-Qi; Lin, Tong-Yu; Xia, Zhong-Jun; Cai QQ*, Chinese Journal of Cancer, 2017.

Updated November 2021 by International Office, Sun Yat-sen University Cancer Center